摘要
目的:比较3种治疗2型糖尿病药物的成本-效果。方法:将186例2型糖尿病患者随机分成3组,分别用阿卡波糖(A组)、二甲双胍(B组)和格列齐特(C组)治疗,并进行药物经济学成本-效果分析。结果:A、B、C组成本分别为776.62、345.55、565.28元;对空腹血糖的总有效率分别为85.5%、84.6%、86.4%,对餐后2h血糖的总有效率分别为95.2%、72.3%、77.9%;对空腹血糖的成本-效果比分别为9.08、4.08、6.54元,对餐后2h血糖的成本-效果比分别为8.16、4.78、7.26元;A、C组相对于B组对空腹血糖的增量成本-效果比分别为478.9、122.1元,对餐后2h血糖的增量成本-效果比分别为18.82、39.23元。结论:控制空腹血糖以二甲双胍为佳;控制餐后血糖或以控制餐后血糖为主时以阿卡波糖为佳。
OBJECTIVE:To compare the cost-effectiveness of3different drugs in the treatment of type2diabetes mellitus.METHODS:186 cases with type 2 diabetes mellitus were randomized to 3 groups:Group A was treated with acarbose;Group B was treated with dimethyl biguanide and Group C was treated with gliclazide.The cost-effectiveness of the three groups was analyzed.RESULTS:The costs for Group A,B and C were 776.62 yuan,345.55 yuan and 565.28 yuan respecˉtively;the total effective rates on blood-fasting sugar were 85.5%,84.6% and 86.4% respectively;the total effective rates on blood sugar 2 hours after meal were 95.2%,72.3% and 77.9% respectively;the cost-effectiveness ratio on blood-fasting sugar were 9.08 yuan,4.08 yuan and6.54yuan respectively;the cost-effectiveness ratio on blood sugar 2 hours after meal were 8.16 yuan,4.78 yuan and7.26 yuan respectively;the increments of cost-effectiveness ratios of group A and C on blood-fasting sugar were478.9yuan and122.1yuan respectively as against Group B;the increments of cost-effectiveness ratios of Group A and C on blood sugar 2h after meal were 18.82 yuan and 39.23 yuan respectively as against group B.CONˉCLUSION:It is better to use dimethyl biguanide to control blood-fasting sugar level while it is better to use acarbose to control the level of postprandial blood sugar or take the controlling of postprandial blood sugar as priority.
出处
《中国药房》
CAS
CSCD
北大核心
2005年第13期994-995,共2页
China Pharmacy
关键词
2型糖尿病
阿卡波糖
二甲双胍
格列齐特
成本-效果分析
Type 2 diabetes mellitus
Acarbose
Dimethyl biguanide
Gliclazide
Cost-effectiveness analysis